Management of Osteoporosis
Key Points
Key Points
Clinicians are advised to assess fracture risk using established tools.
- For those with substantial risk of osteoporotic fracture the clinician should obtain a bone mineral density.
The bone health of all patients may benefit from optimizing nutrition, exercise and lifestyle.
When a pharmacologic agent is indicated, bisphosphonates or denosumab, at osteoporosis-indicated dosages, are the preferred interventions.
Assessment
...essment...
...isk
...n 1.1. It is recommended that patients...
....2. Clinicians should be aware that the pa...
...ion 1.3. Clinicians may use a risk...
...eening...
...endation 2.1. Patients with non-metastatic c...
...2.2. Patients with non-metastatic...
Treatment
...eatment...
...rmacological Intervention...
...ation 3.1. Clinicians should encourage patients...
...mendation 3.2. Clinicians should active...
...n 3.3. Clinicians should actively enc...
...armacological Intervention...
...n 3.4. For patients with non-metastatic cancer...
...on 3.5. Provided T-score and/or risk assessment (e...
...igure 1. Algorithm for Maintaining...
...eoporotic Fracture Risk FactorsHaving trouble v...
...le 2. Bone Loss Associated with Various Cancer Th...
...ommonly used Bone Modifying Agents for t...
...ble 4. Estimated Drug Costs for Bone Modifying Age...